Prostate Cancer Market Historical Overview 2018 – 2027; Booming Growth Seen in Healthcare Sector | by product type hormone therapy, targeted therapies, etc. – Says MRFR

“Prostate Cancer Market”
Universal “Prostate Cancer” Report examines the market position and viewpoint of the market globally, from various angles, such as key players, geological regions, by component, Market Dynamics, Drivers, and Technology Trends & Assessment. And also cover the other information such as Prostate Cancer Market trends, Prominent players, chapter-wise Description followed by various user perceptions and Forecast till 2027.

Prostate Cancer Market – Overview:

The global prostate cancer market is showing the steady growth; mainly owing to increase in patient population. According to report published by Centers for Disease Control and Prevention, in 2014, there were around 172,258 men in the United States, who diagnosed with prostate cancer and around 28,343 men died from prostate cancer. These rising number of prostate cancer create an opportunity for the player to introduce innovative treatment option.

Companies are continuously invent new treatment to capture the global market. Thus players invest more in research and development activities. In this regards, Bayer Pharma AG announced that they have many drugs for the treatment of prostate cancer in there pipeline such as Radium-223 dichloride and BAY 1841788 (ODM-201, AR antagonist).

Avail Premium sample copy @ https://www.marketresearchfuture.com/sample_request/1580 .

Progenics Pharmaceuticals, Inc., 2015, acquired Exini Diagnostics AB in order to support its imaging and therapeutic agents with sophisticated analytical tools and other technologies to help patients and physicians understand, target and treat prostate cancer. These companies are more investing in research and development program to provide the best treatment option, which help them to keep ahead with their competitor.

These acquisitions help companies to provide better treatment opportunity in the market and hence improve the quality of life for the people around the world. Additionally it help market players in translating breakthrough science into innovative treatment to help people with prostate cancer worldwide.

Prostate cancer Market Drivers:

Growing screening and incidence of prostate cancer coupled with the growing awareness are the prime drivers of the market. According to the American Cancer Society’s 2018 prostate cancer estimates, about 164,690 new cases of prostate cancer accounting to 29,430 deaths are likely to occur in the U.S. Prostate cancer is the second leading cause of cancer death in American men after lung cancer with approximately 1 man in 41 dying of prostate cancer or its complications.

The growth in risk factors such as genetic predisposition, aging, smoking, alcoholism, and others are feeding the market as older population, and African-American men have a greater propensity of developing it. Almost 60 % of cases of prostate cancer occur in men aged 65 or older.

The development of prostate-specific antigen (PSA) testing and development of drugs such as 5α-reductase inhibitors are other drivers of the market. The high 5-year survival rate of 99 % has ensured high expenditure to control prostate cancer. The shift of prostate cancer to the developing world is represented by the fact that it is the most common cancer in males in 85 countries, thereby assuring a large market.

Prostate cancer Market Major Players:

Some of the leading players in this market are OncoGenex Pharmaceuticals Inc. (US), OncBioMune Pharmaceuticals Inc. (US), Endo Pharmaceuticals Inc., Tokai Pharmaceuticals, Inc. Bayer Pharma AG (Berlin), Progenics Pharmaceuticals, Inc. (US), TOLMAR Inc. (US), and others.

Avail Illustrious Discount @ https://www.marketresearchfuture.com/check-discount/1580 .

Restraints:

The slow growth and dormant nature of prostate cancer and confined nature which may not cause serious harm or complications hamper the market. Some prostate cancer types need minimal or no treatment, which further constrains the market. The side effects of and risks and the high cost of treatment coupled with curative treatment such as prostatectomy is another deterrent to market growth.

Prostate Cancer Market Segments:

The report has been segmented by product type, end users, and regions to develop a detailed view of the global prostate cancer market.

Based on product type, the market is segmented by targeted therapies, hormone therapy therapeutic vaccines, and others.

Based on end users, the market is segmented by hospitals, clinics, and others.

Based on regions, the market is segmented by North America, Europe, Asia Pacific, Middle East and Africa.

Regional Analysis:

The Americas led by the U.S. dominates the Global Prostate Cancer Market on account of the well-developed healthcare sector, high healthcare expenditure, and excellent insurance penetration.

Europe led by Germany, France, and U.K. Accounts for the second largest market owing to well-developed healthcare infrastructure, large patient pool, and high per capita income. The Asia Pacific is expected to be the fastest growing region led by India and China owing to shift of the disease towards the developing region, huge patient population, growing income and developing economy.

The Middle East & Africa market is anticipated to account for a moderate growth due to poor economic condition, poor healthcare penetration, and social conditions. The Middle East & Africa market is expected to be dominated by Gulf economies of Saudi Arabia, UAE, Kuwait, and Qatar.

TOC of Prostate Cancer Market:

1 INTRODUCTION

1.1 DEFINITION

1.2 SCOPE OF STUDY

1.2.1 RESEARCH OBJECTIVE

1.2.2 ASSUMPTIONS & LIMITATIONS

1.2.2.1 ASSUMPTIONS

1.2.2.2 LIMITATIONS

1.3 MARKET STRUCTURE:

2 RESEARCH METHODOLOGY

2.1 RESEARCH PROCESS:

2.2 PRIMARY RESEARCH

2.3 SECONDARY RESEARCH:

3 MARKET DYNAMICS

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 MACROECONOMIC INDICATORS

4 MARKET FACTOR ANALYSIS

4.1 PORTERS FIVE FORCES MODEL

4.2 BARGAINING POWER OF SUPPLIERS

4.3 BARGAINING POWER OF BUYERS

4.4 THREAT OF NEW ENTRANTS

4.5 THREAT OF SUBSTITUTES

4.6 INTENSITY OF RIVALRY

5. GLOBAL PROSTATE CANCER MARKET, BY TREATMENT

5.1 CHEMOTHERAPY

5.1.1 ANTIMETABOLITES

5.1.2 ANTHRACYCLINES

5.1.3 TAXANES

5.1.4 ALKYLATING AGENTS.

5.2 SURGERY & RADIATION THERAPY

5.3 TARGETED THERAPY

5.3.1 TYROSINE KINASE INHIBITORS

5.3.2 MONOCLONAL ANTIBODIES

5.4 BIOLOGIC THERAPY

5.5 HORMONE THERAPY

5.5.1 ESTROGEN-RECEPTOR MODULATORS (SERMS)

5.5.2 AROMATASE INHIBITORS

5.5.3 OTHERS

5.6 VACCINES

5.7 OTHER

6. GLOBAL PROSTATE CANCER MARKET, BY END USERS

& more…

Key Questions Answered In This Report:

What will the market size and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

Demand for customized Report, with Latest Advancement @ https://www.marketresearchfuture.com/enquiry/1580 .

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/prostate-cancer-market-1580